Endo International plc


ENDP

Price

0.3677


Change

-0.0223


High

0.3974


Low

0.3624


Avg Volume

27,820,816


PE Ratio

-0.12


52 Week High

7.07


52 Week Low

0.28



Profile

Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system. Endo was created as a result of a management buyout from DuPont Merck in 1997 led by Carol Ammon.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.